Cargando…

Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2

Dysregulation of deubiquitination has been reported to contribute to carcinogenesis. However, the function and mechanism of deubiquitinating enzyme 26S proteasome non‐ATPase regulatory subunit 14 (PSMD14) in the progression of ovarian cancer (OV), the deadliest gynecological cancer, still remains to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Tianshui, Liu, Zhuonan, Bi, Fangfang, Yang, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637564/ https://www.ncbi.nlm.nih.gov/pubmed/34382324 http://dx.doi.org/10.1002/1878-0261.13076

Ejemplares similares

Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance
por: Zhang, Ling, et al.
Publicado: (2020)

SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer
por: Sun, Tianshui, et al.
Publicado: (2020)

TMEM119 facilitates ovarian cancer cell proliferation, invasion, and migration via the PDGFRB/PI3K/AKT signaling pathway
por: Sun, Tianshui, et al.
Publicado: (2021)

Deubiquitinase PSMD7 promotes the proliferation, invasion, and cisplatin resistance of gastric cancer cells by stabilizing RAD23B
por: Wang, Jianjiang, et al.
Publicado: (2021)

PSMD12 promotes glioma progression by upregulating the expression of Nrf2
por: Wang, Zhongyong, et al.
Publicado: (2021)

Depletion of PSMD14 suppresses bladder cancer proliferation by regulating GPX4
por: Jia, Changxin, et al.
Publicado: (2023)

PSMD8 can serve as potential biomarker and therapeutic target of the PSMD family in ovarian cancer: based on bioinformatics analysis and in vitro validation
por: Li, Xiao, et al.
Publicado: (2023)

PSMD2 promotes the progression of bladder cancer and is correlated with immune infiltration
por: Wang, Song, et al.
Publicado: (2022)

PHGDH Is Upregulated at Translational Level and Implicated in Platin-Resistant in Ovarian Cancer Cells
por: Bi, Fangfang, et al.
Publicado: (2021)

Corrigendum: PHGDH Is Upregulated at Translational Level and Implicated in Platin-Resistant in Ovarian Cancer Cells
por: Bi, Fangfang, et al.
Publicado: (2022)

The role of ubiquitination and deubiquitination in cancer metabolism
por: Sun, Tianshui, et al.
Publicado: (2020)

Mechanisms orchestrating the enzymatic activity and cellular functions of deubiquitinases
por: Estavoyer, Benjamin, et al.
Publicado: (2022)

The prognostic role of PSMD14 in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2022)

METTL14-mediated N(6)-methyladenosine modification of ITGB4 mRNA inhibits metastasis of clear cell renal cell carcinoma
por: Liu, Zhuonan, et al.
Publicado: (2022)

PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer
por: Zhang, Hanpu, et al.
Publicado: (2022)

The prognostic value of USP14 and PSMD14 expression in non-small cell lung cancer
por: Lei, Jian, et al.
Publicado: (2021)

An Arsenite Relay between PSMD14 and AIRAP Enables Revival of Proteasomal DUB Activity
por: Sukenik, Sigalit, et al.
Publicado: (2021)

Targeting PSMD14 inhibits melanoma growth through SMAD3 stabilization
por: Yokoyama, Satoru, et al.
Publicado: (2020)

Identification of PSMD14 as a potential novel prognosis biomarker and therapeutic target for osteosarcoma
por: Gong, Yubao, et al.
Publicado: (2021)

METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression
por: Liu, Zhuonan, et al.
Publicado: (2021)

The Proteasomal Deubiquitinating Enzyme PSMD14 Regulates Macroautophagy by Controlling Golgi-to-ER Retrograde Transport
por: Bustamante, Hianara A, et al.
Publicado: (2020)

Deubiquitinase USP19 extends the residual enzymatic activity of phenylalanine hydroxylase variants
por: Sarodaya, Neha, et al.
Publicado: (2022)

The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP
por: Zhu, Xiaolin, et al.
Publicado: (2021)

PSMD2 contributes to the progression of esophageal squamous cell carcinoma by repressing autophagy
por: Liu, Yachen, et al.
Publicado: (2023)

Haploinsufficiency of PSMD12 Causes Proteasome Dysfunction and Subclinical Autoinflammation
por: Yan, Kai, et al.
Publicado: (2022)

PKM2, function and expression and regulation
por: Zhang, Ze, et al.
Publicado: (2019)

Long non‐coding RNA VAL facilitates PKM2 enzymatic activity to promote glycolysis and malignancy of gastric cancer
por: Dai, Ting, et al.
Publicado: (2022)

PSMD7 downregulation suppresses lung cancer progression by regulating the p53 pathway
por: Xu, Xinchun, et al.
Publicado: (2021)

PSMD1 and PSMD2 regulate HepG2 cell proliferation and apoptosis via modulating cellular lipid droplet metabolism
por: Tan, Yanjie, et al.
Publicado: (2019)

26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy
por: Rubio, Andres J., et al.
Publicado: (2021)

Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progression
por: Qian, Meijia, et al.
Publicado: (2021)

PSMD14 Targeting Triggers Paraptosis in Breast Cancer Cells by Inducing Proteasome Inhibition and Ca(2+) Imbalance
por: Lee, Hong-Jae, et al.
Publicado: (2022)

Correction to: PKM2, function and expression and regulation
por: Zhang, Ze, et al.
Publicado: (2019)

The 26S Proteasome Regulatory Subunit GmPSMD Promotes Resistance to Phytophthora sojae in Soybean
por: Liu, Tengfei, et al.
Publicado: (2021)

SUMOylation of HSP27 regulates PKM2 to promote esophageal squamous cell carcinoma progression
por: Zhang, Xiao, et al.
Publicado: (2020)

PKM2 Promotes Breast Cancer Progression by Regulating Epithelial Mesenchymal Transition
por: Xiao, Hui, et al.
Publicado: (2020)

The deubiquitinase USP7 promotes HNSCC progression via deubiquitinating and stabilizing TAZ
por: Li, Jin, et al.
Publicado: (2022)

Regulation of Drp1 and enhancement of mitochondrial fission by the deubiquitinating enzyme PSMD14 facilitates the proliferation of bladder cancer cells
por: Song, Wei, et al.
Publicado: (2023)

Research Progress for Targeting Deubiquitinases in Gastric Cancers
por: An, Tao, et al.
Publicado: (2022)

PSMD9 expression predicts radiotherapy response in breast cancer
por: Langlands, Fiona E, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_obmm0iup5qo3kcc97e08p50814